Metagenomi is discovering breakthrough gene editing systems for curing genetic disease.
Location: United States, California, Emeryville
Employees: 51-200
Total raised: $415M
Founded date: 2018
Investors 8
Funding Rounds 4
| Date | Series | Amount | Investors |
| 06.01.2023 | Series B | $100M | - |
| 25.01.2022 | Series B | $175M | PFM Health... |
| 07.04.2021 | Series A | $75M | - |
| 12.11.2020 | Series A | $65M | Leaps by B... |
Mentions in press and media 17
| Date | Title | Description |
| 02.12.2025 | AWS re:Invent Day 2: Amazon Launches New AI Models, Trainium3 Chips, and On-Prem AI Factories | Image: Amazon The second day of AWS re:Invent arrived with the same loud energy as opening day, as Amazon pushed deeper into AI hardware, new models, and tools that promise faster building, faster training, and faster modernization. Here ar... |
| 09.02.2024 | Does Moderna’s RSV vaccine lose efficacy faster than others? | Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Our podcast this week centers exclusively on a tantalizing subject: Artificial intelligence in biotech. Give it a li... |
| 27.01.2022 | Metagenomi Closes $175M Series B | EMERYVILLE, CA, Metagenomi, a genetic medicines company, has closed an oversubscribed $175 million Series B financing. >> Click here for more funding data on Metagenomi >> To export Metagenomi funding data to PDF and Excel, ... |
| 26.01.2022 | Metagenomi raises $175M Series B | Metagenomi has raised $175 million in a round co-led by PFM Health Sciences and Farallon Capital Management. The company is developing therapeutics using gene editing tools to treat metabolic and cardiovascular diseases and more. Select Add... |
| 25.01.2022 | Metagenomi Closes Oversubscribed $175M Series B Financing to Advance Therapeutic Pipeline and Expand Novel Gene Editing Platform | Metagenomi, a genetic medicines company with a versatile portfolio of next-generation gene editing tools, today announced the completion of an up-sized and oversubscribed $175 million Series B financing. This brings the total amount of fu... |
| 10.01.2022 | Pfizer's $1 billion bet on an ultraprecise CRISPR technology could signal that more gene-editing deals are on the horizon for Big Pharma | Albert Bourla, the CEO of Pfizer. Crystal Cox/Insider This story is available exclusively to Insider subscribers. Become an Insider and start reading now. Redeem now Pfizer is getting into the hot field of gene editing. It announced a new r... |
| 07.04.2021 | Metagenomi Extends Series A Financing to $75M | Metagenomi, an Emeryville, Calif.-based gene editing company, extended and closed its Series A financing, bringing the round to a total of $75m. The round was led by RA Capital Management, which joined the Series A investor syndicate, inclu... |
| 24.11.2020 | Healthcare startups that raised funding week of Nov 16-20 | Sofia, Metagenomi, Strava, Elevation Oncology among the companies landing fresh capital Adaptilens: Adaptilens is a Boston-based maker of an injectable lens for improving vision. Adaptilens has raised $1.6 million in seed funding led by Pil... |
| 13.11.2020 | BAYER AG Bayer : Metagenomi closes USD 65 million Series A financing led by Leaps by Bayer and Humboldt Fund | California - Metagenomi, a next generation gene editing company launched by UC Berkeley scientists in 2018, successfully completed a USD 65 million Series A financing round and emerged from stealth mode today. The Series A round was led by ... |
| 13.11.2020 | Bayer : Metagenomi closes USD 65 million Series A financing led by Leaps by Bayer and Humboldt Fund | California - Metagenomi, a next generation gene editing company launched by UC Berkeley scientists in 2018, successfully completed a USD 65 million Series A financing round and emerged from stealth mode today. The Series A round was led by ... |
Show more